Case studyFortune 100: 80% less compliance workRead the Story
RiskWatch
Updated May 15, 2026 · 10 platforms evaluated

Top 10 Risk Management Software for Medical Devices in 2026: ISO 14971, ISO 13485, FDA QMSR, and EU MDR Compared

Honest 2026 ranking of the 10 best medical device risk and quality platforms covering ISO 14971, ISO 13485, FDA QMSR, EU MDR, IEC 62366, and IEC 62304.

By RiskWatch Editorial · Medical Device Risk and Compliance Software Research

Verdict

TL;DR

If a medical device manufacturer, in vitro diagnostic (IVD) maker, or contract manufacturer needs one platform covering ISO 14971:2019 risk management, ISO 13485:2016 quality management, FDA QMSR under 21 CFR Part 820 (effective February 2 2026), EU MDR 2017/745 and IVDR 2017/746, IEC 62366-1 usability engineering, IEC 62304 software lifecycle for software as a medical device (SaMD), and the FDA premarket cybersecurity guidance finalised October 2023, RiskWatch ranks first on our weighted score because of its 40+ pre-mapped framework library, single-tenant deployment for design history file (DHF) and design master record (DMR) data residency, and a published support ladder starting at 99 dollars per month. Greenlight Guru is the strongest pick for venture-stage medical device manufacturers that want a device-native electronic quality management system (eQMS) built around ISO 14971 risk and Design Controls; MasterControl wins for FDA-inspected manufacturers; Veeva Vault QualityOne fits enterprises already standardised on the Vault platform; ETQ Reliance and Sparta TrackWise Digital remain strong for mid-market and global enterprises; Qualio fits sub-100-employee Class II startups; Pilgrim SmartSolve remains the IQVIA-owned heritage option. Pick by FDA inspection track record, EU MDR notified-body submission history, ISO 14971:2019 process depth, and renewal-pricing transparency, because seven of the ten vendors here will not publish a list price.

Pick by use case

Where each platform fits

Multi-framework ISO 14971 + ISO 13485 + QMSR + EU MDR under one tenant with single-tenant deployment
RiskWatch: ISO 14971:2019, ISO 13485:2016, FDA QMSR / 21 CFR Part 820 (effective February 2 2026), EU MDR 2017/745, IVDR 2017/746, IEC 62366-1, IEC 62304, and FDA cybersecurity premarket pre-mapped under one tenant; single-tenant deployment for DHF and DMR data residency; 99 dollars per month entry tier published.
Device-native eQMS for venture-stage and growth-stage manufacturers
Greenlight Guru: Built only for medical devices since 2013; ISO 14971:2019 risk model, Design Controls under 21 CFR 820.30, EU MDR Annex II technical documentation, and IEC 62304 software lifecycle out of the box; 1,000+ device-only customer base.
FDA-regulated manufacturers that want a purpose-built eQMS with pre-validated Part 820 and QMSR controls
MasterControl: FDA itself uses MasterControl internally per vendor disclosure; deepest Part 820 / QMSR controls testing in this ranking; 1,100+ life-sciences customers including major Class II and Class III device manufacturers.
Vault-standardised device enterprises that want quality plus regulatory plus clinical under one Veeva contract
Veeva Vault QualityOne: QualityOne is the Veeva Vault application built specifically for device-side quality outside the broader pharma-focused Vault QMS; native to the Vault platform alongside RIM, Clinical, and QualityDocs; strongest enterprise device reference base after MasterControl.
Mid-market device + IVD manufacturers with deep supplier qualification needs
ETQ Reliance: Hexagon AB subsidiary since August 2022; Reliance NXG cloud-native architecture with no-code configuration; 40+ pre-built applications including device-specific Design Controls and CAPA; deep supplier rating and supplier-audit modules.
Largest installed device + diagnostic quality base with Honeywell stewardship
Sparta TrackWise Digital: TrackWise has run device quality systems since 1994; Honeywell acquired Sparta January 2021 for 1.3 billion dollars; AI-Enriched Quality Outcomes shipped 2024-2025 with Honeywell Forge under the data layer.
Sub-100-employee Class II startups that want a fast-deploy validated eQMS
Qualio: Cloud-native multi-tenant eQMS; 60-90-day time to validated deployment; G2 Leader for SMB QMS at 4.6 out of 5 across 380+ reviews; transparent published pricing on Essentials tier.
IQVIA-backed heritage eQMS for large device + diagnostic manufacturers
Pilgrim SmartSolve: IQVIA subsidiary since 2015; SmartSolve eQMS plus iComplyGRC for compliance and supplier risk; 800+ regulated life-sciences customers; 30-year operating history with regulated medical-device and IVD manufacturers.
Public device companies running SOX 404 plus internal audit alongside the eQMS
Optro (formerly AuditBoard): 1,585 G2 reviews at 4.6 out of 5; deepest SOX controls testing in the category; CrossComply ties HIPAA, HITRUST, NIST, and ISO 27001 to the SOX evidence layer for public-device audit committees and ICFR.
Product liability plus clinical-trial claims plus recall management at scale
Riskonnect: Salesforce-native RMIS plus claims; only platform unifying RMIS, claims, and integrated risk under one data model; deep product liability and clinical-trial insurance modules tied to recall workflow for device manufacturers.

Medical device risk management software is a fractured category because device makers carry four overlapping risk programmes under one roof, and each programme reads from a different regulator. A Director of Quality wants an electronic quality management system (eQMS) covering Design Controls under 21 CFR 820.30, the FDA Quality Management System Regulation (QMSR) under 21 CFR Part 820 effective February 2 2026, ISO 13485:2016 (now incorporated by reference into the QMSR), nonconforming product, CAPA, and complaint handling. A Director of Risk Management or Product Risk wants ISO 14971:2019 risk analysis, risk evaluation, risk control, residual risk evaluation, and benefit-risk determination across the lifecycle. A Director of Regulatory Affairs wants EU MDR 2017/745 (date of application May 26 2021) and IVDR 2017/746 technical documentation, notified-body submissions, and post-market surveillance plus IEC 62366-1 usability engineering for human factors. A VP of Software Engineering wants IEC 62304 software lifecycle for software as a medical device (SaMD) and the FDA premarket cybersecurity guidance finalised October 2023. The ten platforms in this ranking each cover at least two of those jobs well, and none of them serves all four equally well.

We considered 24 platforms across the LNS Research EQMS leaderboard for medical devices, the Gartner Magic Quadrant for Quality Management System Software, G2 Grid for Medical Device QMS, Capterra Shortlist for life-sciences GRC, and vendor 10-K filings. We cut to ten by removing near-duplicates (Cognidox and Matrix Requirements against Greenlight Guru for venture-stage device buyers), excluding pure trust-management platforms that do not run a device risk register or design history file, and excluding ERP-bundled quality modules (SAP QM, Oracle Agile PLM Quality, PTC Windchill QMS) that device manufacturers rarely shortlist standalone for the post-market quality and risk brief. AssurX and Intelex were considered but ranked tenth and eleventh internally; the eventual ten are the ten a real Director of Quality at a Class II or Class III device manufacturer would shortlist in 2026.

Pricing transparency is worse in medical-device quality than in general GRC. Seven of the ten platforms here will not publish a list price, and one of those seven is RiskWatch. RiskWatch publishes Standard at 99 dollars per month and Professional at 36,000 dollars per year; Greenlight Guru and Qualio publish entry tiers; the remaining seven gate pricing behind a demo. We have triangulated prices for the opaque vendors from SmartSuite, ComplianceRated, LNS Research teardowns, OpenRegulatory's QMS Comparison, and direct-published price ranges where available, and dated each estimate. Where a vendor will not let us publish a number, we say so.

At-a-glance

Comparison table

The 10 platforms scored on the methodology weights at the bottom of this page. Pricing-transparency pill is the buyer-honesty signal.

RankProductBest forPricing transparencyG2Verdict
1RiskWatch
RiskWatch International
Class II and Class III medical device manufacturers, IVD makers, and contract manufacturers running 3+ frameworks (FDA QMSR + ISO 13485 + EU MDR + ISO 14971) who want one tenant covering risk assessment, supplier qualification, and audit-evidence with single-tenant DHF data residency.Partial4.5/5
60+ reviews
ISO 14971:2019, ISO 13485:2016, FDA QMSR / 21 CFR Part 820, EU MDR 2017/745, IVDR...
2Greenlight Guru
Greenlight Guru, Inc.
Venture-stage and growth-stage medical device manufacturers (10-500 employees) building a Class II or Class III device that want a device-native eQMS with ISO 14971 risk and Design Controls out of the box.Opaque4.6/5
1050+ reviews
Only platform built exclusively for medical devices since 2013; ISO 14971:2019 risk...
3MasterControl
MasterControl Solutions, Inc.
FDA-regulated medical device manufacturers and IVD makers that need a purpose-built closed-loop eQMS with pre-validated 21 CFR Part 820 / QMSR controls and FDA inspection track record.Opaque4.3/5
380+ reviews
FDA itself uses MasterControl internally per vendor disclosure; the strongest single...
4Veeva Vault QualityOne
Veeva Systems Inc.
Top-tier medical device enterprises already standardised on the Veeva Vault platform who want QualityOne, RIM, QualityDocs, Training, and Clinical under one vendor.Opaque4.4/5
220+ reviews
Vault QualityOne is purpose-built for medical-device and consumer-products quality,...
5ETQ Reliance
ETQ (a Hexagon company)
Mid-market medical-device and IVD manufacturers (500-5,000 employees) that want a configurable QMS with deep supplier management and the option to expand to multiple plants under one tenant.Opaque4.3/5
220+ reviews
30+ year operating history with quality management across medical-device, IVD, and...
6Sparta TrackWise Digital
Sparta Systems (a Honeywell company)
Mid-large medical-device and IVD manufacturers with an existing TrackWise on-prem footprint or a Honeywell Connected Enterprise relationship who want cloud-native eQMS with AI-enriched analytics.Opaque4.1/5
150+ reviews
30-year operating history with device and diagnostic quality systems; TrackWise has...
7Qualio
Qualio, Inc.
Sub-100-employee Class II medical-device and IVD startups that need a fast-deploy validated eQMS with transparent published entry pricing.Partial4.6/5
400+ reviews
Cloud-native multi-tenant SaaS with 60-90 day time to validated deployment for...
8Pilgrim SmartSolve
Pilgrim Quality Solutions (an IQVIA company)
Large device + diagnostic manufacturers with existing IQVIA clinical-research or RIM contracts who want a heritage eQMS with deep CAPA + complaint + supplier modules under one IQVIA vendor relationship.Opaque4.1/5
130+ reviews
30-year operating history with regulated device and diagnostic quality systems
9Optro (formerly AuditBoard)
Optro, Inc.
Public medical-device companies and Fortune 1000 internal-audit teams running SOX 404 + ICFR who want one platform across internal audit, SOX, third-party, and ESG alongside their separate device eQMS.Opaque4.6/5
1820+ reviews
1,585 G2 reviews at 4.6 out of 5 (May 2026); the highest review volume in this ranking
10Riskonnect
Riskonnect, Inc.
Medical-device and IVD enterprises with significant product liability exposure or self-insured clinical-trial portfolios that need claims + RMIS + recall management in one Salesforce-native tenant alongside their device eQMS.Opaque4.2/5
200+ reviews
Deepest claims administration and RMIS in this ranking (Ventiv Technology acquisition...
Calculator

Estimate the licence cost

Drag the slider to your headcount. Estimates use each vendor's published or triangulated tiers. Opaque vendors show Contact sales.

500
11.3k2.5k3.8k5k
RiskWatch
Standard (≤ 500 employees)
$99/yr
Greenlight Guru
MedTech Suite (est.) (quote-only tier)
Contact sales
MasterControl
Mid-market (est.) (quote-only tier)
Contact sales
Veeva Vault QualityOne
Mid-market (est.) (quote-only tier)
Contact sales
ETQ Reliance
Mid-market (est.) (quote-only tier)
Contact sales
Sparta TrackWise Digital
Mid-market (est.) (quote-only tier)
Contact sales
Qualio
Enterprise (est.) (quote-only tier)
Contact sales
Pilgrim SmartSolve
Mid-market (est.) (quote-only tier)
Contact sales
Optro (formerly AuditBoard)
Starter (est.) (quote-only tier)
Contact sales
Riskonnect
Enterprise entry (est.) (quote-only tier)
Contact sales

Estimates only. Opaque-pricing vendors do not publish list prices; bands are triangulated from public third-party sources dated 2026-05-15. Implementation services, module add-ons, and renewal escalators are extra.

Pick your own weights

Decision matrix

Default weights match the methodology at the bottom of this page. Drag the sliders to match your priorities and re-rank in real time.

20%

How quickly a non-technical control owner reaches first value

20%

Module coverage across ERM, IT, audit, TPRM, BC

20%

Price to value ratio at mid-market

15%

Quality and responsiveness of vendor support

15%

Handling 5,000+ employees, multiple entities, regions

10%

Breadth of native connectors and APIs

Weights sum: 100%
  1. 1
    RiskWatch
    Editorial rank #1
    8.69
  2. 2
    Greenlight Guru
    Editorial rank #2
    8.43
  3. 3
    Optro (formerly AuditBoard)
    Editorial rank #9
    8.34
  4. 4
    Veeva Vault QualityOne
    Editorial rank #4
    8.33
  5. 5
    Qualio
    Editorial rank #7
    8.33
  6. 6
    MasterControl
    Editorial rank #3
    8.23
  7. 7
    ETQ Reliance
    Editorial rank #5
    8.18
  8. 8
    Sparta TrackWise Digital
    Editorial rank #6
    8.07
  9. 9
    Riskonnect
    Editorial rank #10
    8.05
  10. 10
    Pilgrim SmartSolve
    Editorial rank #8
    7.88
Switching cost

Migration matrix

Read row-to-column. Row = today's platform, column = tomorrow's. Colour reflects realistic switching effort, not vendor sales pitches.

From / To
RiskWatch
Greenlight Guru
MasterControl
Veeva Vault QualityOne
ETQ Reliance
Sparta TrackWise Digital
Qualio
Pilgrim SmartSolve
Optro
Riskonnect
RiskWatch.EMMMMEMEH
Greenlight GuruE.MMMHEHEH
MasterControlEE.EEEEEEH
Veeva Vault QualityOneEEE.EMEMEH
ETQ RelianceEEEE.EEEEH
Sparta TrackWise DigitalEEEEE.EEEH
QualioEEHMHH.HEH
Pilgrim SmartSolveEEEEEEE.EH
OptroEEMMMMEM.H
RiskonnectHHHHHHHHH.
Easy (E)Moderate (M)Hard (H)Source: per-vendor migration field with radar-profile fallback. Treat as a directional guide, not a quote.
Methodology

How we scored and why you should trust it

The methodology is the only thing keeping this page honest. Read it carefully and apply your own weights in the decision matrix above.

We scored each of the ten platforms on six axes calibrated for a US and EU medical-device buyer at a Class II or Class III manufacturer or IVD maker: Ease of Use (20%), Feature Breadth across ISO 14971 risk + Design Controls + QMSR + EU MDR + IEC 62366 + IEC 62304 + FDA cybersecurity (20%), Value (20%), Customer Support (15%), Scalability across multi-site and multi-region manufacturing (15%), and ERP + PLM + ALM Integrations (10%). Scores are 0-10 and calibrated within this category (highest features 9.5, lowest 6.5). Ratings reference G2, Capterra, Gartner Peer Insights, and LNS Research figures pulled 2026-05-15. Pricing reflects the most-recent published or triangulated figures, also pulled 2026-05-15; where pricing is opaque we report a range based on two or more public third-party sources. We re-verify this page quarterly. We accept no affiliate fees, sponsorship money, or paid placements on this page.

Weights used in the editorial ranking

Ease of use
20%
Feature breadth
20%
Value
20%
Customer support
15%
Scalability
15%
Integrations
10%
#1

RiskWatch

RiskWatch International · Founded 1993 · Annapolis, MD, USA

Medical device risk and compliance platform with ISO 14971, ISO 13485, FDA QMSR, EU MDR, IEC 62366, and IEC 62304 pre-mapped.

Partial pricingG2 4.5 · Capterra 4.6 · 60+ reviews

Summary

RiskWatch ships a device-friendly risk and compliance assessment platform built around pre-mapped control libraries for ISO 14971:2019 application of risk management, ISO 13485:2016 quality management for medical devices, FDA Quality Management System Regulation (QMSR) under 21 CFR Part 820 effective February 2 2026, EU Medical Device Regulation 2017/745 (MDR) and In Vitro Diagnostic Regulation 2017/746 (IVDR), IEC 62366-1:2015 usability engineering, IEC 62304 medical device software lifecycle, FDA Cybersecurity in Medical Devices premarket guidance finalised October 2023, and 30+ other frameworks. The platform runs on a survey-based assessment engine, a cross-mapped control library that auto-detects shared controls across QMSR and ISO 13485 since the two are now harmonised by reference, and an evidence vault that supports the ISO 14971 risk management file directly. Customers include state agencies, multi-hospital health systems, payers, medical device companies, and contract manufacturers. The pricing model is partially opaque on the public site but Standard at 99 dollars per month and Professional at 36,000 dollars per year are published; the single-tenant deploy architecture means device makers retain full control of design history file (DHF) and design master record (DMR) data.

Strengths
  • ISO 14971:2019, ISO 13485:2016, FDA QMSR / 21 CFR Part 820, EU MDR 2017/745, IVDR 2017/746, IEC 62366-1, IEC 62304, and FDA cybersecurity premarket guidance pre-mapped so one evidence item satisfies FDA, EU notified-body, and ISO 13485 audits
  • Single-tenant deployment with customer-owned data residency, which matters for DHF and DMR retention required under 21 CFR 820.181 and for EU MDR Article 10(8) technical documentation retention
  • 33-year operating history with federal customers (US Department of Defense, VA, DOJ per public press); long bench in regulated industries with FDA inspection exposure
  • Vendor risk management module supports supplier qualification and supplier audit required under 21 CFR 820.50 and ISO 13485 section 7.4 purchasing controls, including critical-supplier risk classification
  • Physical security assessment module supports IEC 81001-5-1 and FDA cybersecurity guidance physical-security controls for connected device manufacturing sites
  • Survey-based assessment engine works for non-technical control owners; design engineers, regulatory affairs, and quality engineers can complete ISO 14971 hazard-analysis surveys without IT translation
  • Published support tier ladder starting at 99 dollars per month Standard; rare in this category where seven of ten vendors gate pricing entirely
Weaknesses
  • Not a purpose-built device eQMS at the depth that Greenlight Guru, MasterControl, Veeva Vault QualityOne, ETQ Reliance, Sparta TrackWise Digital, Qualio, or Pilgrim SmartSolve ship; RiskWatch runs the risk and assessment layer rather than a closed-loop Design Controls, CAPA, and change-control workflow tied to the DHF and DMR
  • No native PLM, ALM, or design-tooling integration; Jama Connect, Polarion ALM, Codebeamer, PTC Windchill, and Siemens Teamcenter integrations are scoped per request rather than shipped pre-built
  • Public pricing is partially opaque above Professional; Enterprise tier is quote-only because device-deployment topology and FDA inspection-readiness profile vary materially
  • Brand recognition on G2 and Capterra for medical-device quality specifically lags Greenlight Guru, MasterControl, Veeva, Qualio, and Sparta; total third-party review volume in the device cohort sits below 100
  • No native ISO 14971:2019 risk-matrix engine at the depth that Greenlight Guru ships; risk-matrix and risk-control documentation runs through the survey and evidence layer rather than a dedicated hazard-trace UI
  • UI shows its operational heritage in places compared to newer SaaS entrants like Greenlight Guru and Qualio for digital-first device customers
Best for

Class II and Class III medical device manufacturers, IVD makers, and contract manufacturers running 3+ frameworks (FDA QMSR + ISO 13485 + EU MDR + ISO 14971) who want one tenant covering risk assessment, supplier qualification, and audit-evidence with single-tenant DHF data residency.

Worst for

Single-product venture-stage device startups whose only need is a closed-loop Design Controls and DHF workflow; Greenlight Guru and Qualio fit that brief better as primary device-native eQMS tools.

Key features

  • ISO 14971:2019 risk management process aligned (hazard identification, risk analysis, risk evaluation, risk control, residual risk, benefit-risk)
  • ISO 13485:2016 medical-device QMS controls (now incorporated by reference into FDA QMSR)
  • FDA QMSR / 21 CFR Part 820 aligned (effective February 2 2026)
  • EU MDR 2017/745 + IVDR 2017/746 technical documentation library
  • IEC 62366-1:2015 usability engineering process alignment
  • IEC 62304:2006 + A1:2015 medical device software lifecycle library
  • FDA cybersecurity premarket submissions content (October 2023 final guidance)
  • Supplier qualification + supplier audit tracking aligned to 21 CFR 820.50 and ISO 13485 section 7.4
  • Evidence vault with versioning and audit-ready export (FDA + EU notified-body inspection pack)
  • Single-tenant deployment for DHF and DMR data residency

Integrations

25+ native. Notable: Microsoft Entra ID (SAML SSO), Okta, Microsoft 365 / SharePoint, Slack, Jira, Salesforce, Custom REST API.

Target size

50 to 50,000 employees · US · Canada · EU · UK · AU

#2

Greenlight Guru

Greenlight Guru, Inc. · Founded 2013 · Indianapolis, IN, USA

Device-native eQMS built only for medical devices with ISO 14971 risk and Design Controls out of the box.

Opaque pricingG2 4.6 · Capterra 4.7 · 1050+ reviews

Summary

Greenlight Guru was founded in 2013 and is the only platform in this ranking built exclusively for medical devices. The platform serves over 1,000 device-only customers across the US, EU, and APAC and was designed around ISO 14971:2019 risk management, Design Controls under 21 CFR 820.30, Document Control, Training, CAPA, Audits, Complaints, Supplier Management, and EU MDR Annex II technical documentation. The MedTech Suite ties quality, clinical, and a separate Risk module under one tenant. JMI Equity led a growth investment in 2021. Strength is device-native depth and the most opinionated ISO 14971:2019 risk model in this ranking; weakness is opaque pricing rumoured in the 5-figure-USD-per-year minimum range and a thinner enterprise reference base than MasterControl or Veeva.

Strengths
  • Only platform built exclusively for medical devices since 2013; ISO 14971:2019 risk model, Design Controls under 21 CFR 820.30, and EU MDR Annex II technical documentation out of the box
  • 1,000+ device-only customers; G2 Leader badge with 1,000+ reviews at 4.6 out of 5
  • MedTech Suite ties quality, clinical, and a separate Risk module under one tenant with shared identity and audit trail
  • Risk Management module aligns with ISO 14971:2019 throughout the product lifecycle and incorporates harmonised IMDRF terms for hazards and harms beyond just FMEA
  • Design Controls workflow ties user-needs, design-inputs, design-outputs, verification, validation, design-reviews, and the DHF in one closed loop
  • JMI Equity growth investment 2021 provides capital depth without majority-control PE renewal dynamics
Weaknesses
  • Pricing is opaque on the public site; Capterra and SmartSuite triangulate Essentials around 25-40K dollars per year and the full MedTech Suite scaling materially above that; OpenRegulatory describes Greenlight as the new kid on the block fuelled by VC money with pricing as opaque as competitors
  • Not a fit for non-device buyers (pure-play pharma, broad GRC); the device-only narrowness is the trade-off
  • Enterprise reference base is thinner than MasterControl, Veeva Vault QualityOne, or Sparta TrackWise Digital; sub-50-FTE startups dominate the install base
  • PE ownership (JMI Equity growth round 2021) raises typical renewal-uplift risk over a 3-year subscription
  • Implementation is consultant-heavy at the higher tiers; expect 60-120 day deployment for the full MedTech Suite with named SI partner support
  • No native LIMS or MES depth; ERP integrations are typically scoped to NetSuite and Sage Intacct rather than SAP or Oracle E-Business Suite
Best for

Venture-stage and growth-stage medical device manufacturers (10-500 employees) building a Class II or Class III device that want a device-native eQMS with ISO 14971 risk and Design Controls out of the box.

Worst for

Top-20 device enterprises with global multi-region deployment needs and 50,000-employee headcounts; MasterControl, Veeva Vault QualityOne, and Sparta TrackWise Digital fit that brief better.

Key features

  • ISO 14971:2019 risk management module with hazard, harm, and IMDRF term library
  • Design Controls workflow under 21 CFR 820.30 with DHF compilation
  • Document Control with revision management and approval workflow
  • Training management aligned to job role and document revision
  • CAPA + nonconforming product + change control closed-loop workflow
  • Audit management (internal + external + notified-body)
  • Supplier management with qualification and supplier-audit
  • Complaint handling tied to device identifier (UDI) and lot
  • EU MDR Annex II technical documentation structure
  • Clinical module for ISO 14155 GCP-aligned device trials (MedTech Suite)

Integrations

25+ native. Notable: Microsoft Entra ID, Okta, NetSuite, Sage Intacct, Jira, Slack, DocuSign.

Target size

10 to 2,000 employees · US · Canada · EU · UK · APAC

#3

MasterControl

MasterControl Solutions, Inc. · Founded 1993 · Salt Lake City, UT, USA

Purpose-built electronic quality management system used by the FDA itself, with deep Part 820 / QMSR controls.

Opaque pricingG2 4.3 · Capterra 4.5 · 380+ reviews

Summary

MasterControl was founded in 1993 in Salt Lake City and is the elder statesman of medical-device and pharmaceutical eQMS. The platform spans Document Control, Training, Deviations, CAPA, Change Control, Audits, Supplier Management, and Validation under one closed-loop quality system. The FDA itself runs MasterControl internally for parts of its document and quality workflow per vendor disclosure. The platform serves 1,100+ life-sciences customers globally including major Class II and Class III device manufacturers, and is recognised as a Leader in the LNS Research EQMS leaderboard. Strength is depth of 21 CFR Part 820 / QMSR controls testing and FDA-internal usage; weakness is implementation cost and a UI that shows its 30-year heritage.

Strengths
  • FDA itself uses MasterControl internally per vendor disclosure; the strongest single regulator-credibility signal in this category
  • Deepest 21 CFR Part 820 / QMSR controls testing in this ranking; pre-validated configurations cut validation effort materially for the February 2 2026 QMSR transition
  • 1,100+ life-sciences customers including major Class II and Class III device manufacturers and IVD makers
  • Closed-loop quality workflow spans Document Control, Training, Deviations, CAPA, Change Control, Audit, Supplier, and Validation in one tenant
  • Recognised as a Leader in the LNS Research EQMS leaderboard for multiple years
  • Manufacturing Excellence (Mx) module ties electronic batch records and electronic Device History Records (eDHR) to the QMS for paperless device shop floors
Weaknesses
  • TA Associates and Sumeru Equity Partners ownership since the 2020 recapitalisation raises the typical PE renewal-uplift risk (8-12% annual reported)
  • Pricing is opaque; SmartSuite and ComplianceRated triangulate 60K-180K dollars entry for mid-size device manufacturers, scaling to high six figures for enterprise
  • Implementation is consultant-heavy; expect 4-9 month deployment timelines with a named SI partner
  • UI shows its 30-year heritage; newer entrants like Greenlight Guru and Qualio feel more modern out of the box for digital-first device startups
  • G2 reviewers (4.3 out of 5 across 350+ reviews) flag a steep learning curve for non-quality users and report module-by-module licensing fatigue
  • ISO 14971:2019 hazard-trace UI is lighter than Greenlight Guru's purpose-built risk module; the risk workflow runs through CAPA and Change Control rather than a dedicated risk-matrix engine
Best for

FDA-regulated medical device manufacturers and IVD makers that need a purpose-built closed-loop eQMS with pre-validated 21 CFR Part 820 / QMSR controls and FDA inspection track record.

Worst for

Sub-50-employee device startups running a single Class II 510(k) submission; the product is over-built and the price reflects it.

Key features

  • 21 CFR Part 820 / QMSR pre-validated cloud platform (effective February 2 2026)
  • 21 CFR Part 11 electronic records and signatures
  • Document Control with revision management and approval workflow
  • Training management aligned to job role and SOP version
  • Deviations + CAPA + Change Control closed-loop workflow
  • Audit management (internal + external + FDA + notified-body)
  • Supplier management with qualification and supplier-audit
  • Manufacturing Excellence (Mx) electronic Device History Records (eDHR)
  • Validation Excellence (Vx) for risk-based GAMP 5 software validation

Integrations

50+ native. Notable: SAP, Oracle, Microsoft Entra ID, Okta, Salesforce, DocuSign, PTC Windchill.

Target size

100 to 50,000 employees · US · Canada · EU · UK · Switzerland · Ireland · APAC

#4

Veeva Vault QualityOne

Veeva Systems Inc. · Founded 2007 · Pleasanton, CA, USA

Veeva's device-side quality application on the Vault platform alongside RIM and Clinical.

Opaque pricingG2 4.4 · Capterra 4.4 · 220+ reviews

Summary

Veeva Systems was founded in 2007 by Peter Gassner and Matt Wallach. Vault QualityOne is Veeva's quality application built specifically for medical-device and consumer-products buyers, distinct from Vault QMS which serves pharmaceutical manufacturers. QualityOne spans Document Control, Training, Deviations, CAPA, Change Control, Audits, Complaints, and Supplier Management. The Vault platform also runs Vault RIM (regulatory information management for 510(k), De Novo, and EU MDR submissions) and Vault Clinical for ISO 14155 device trials, giving QualityOne a unified platform story across the device lifecycle. Strength is the unified Vault platform and cloud-native architecture; weakness is per-user pricing that scales fast at enterprise and the platform tax for non-Vault shops.

Strengths
  • Vault QualityOne is purpose-built for medical-device and consumer-products quality, separate from the pharma-focused Vault QMS line
  • Native to the Vault platform alongside Vault RIM (510(k) and EU MDR submissions), QualityDocs, Training, and Clinical for ISO 14155 device trials
  • Strong enterprise device reference base behind only MasterControl in this ranking; Veeva FY25 10-K reports broad life-sciences adoption
  • Cloud-native multi-tenant architecture with three releases per year cadence; no on-prem upgrade burden
  • 21 CFR Part 11 validation documented at platform level; customers inherit the validation rather than re-running it per release
  • Public company (NYSE: VEEV ~30B dollar market cap) stability; no PE renewal-pressure dynamic
Weaknesses
  • Per-user pricing scales fast; activating QualityOne at enterprise device manufacturers routinely costs 200K-800K dollars per year before negotiation
  • Platform tax for non-Vault shops; if you do not already run Vault RIM, QualityDocs, or Clinical, the value story shrinks materially
  • G2 reviewers flag a learning curve and complex configuration; SI partner engagements are typical for greenfield deployments
  • Less natural fit for venture-stage Class II startups; the platform is engineered for enterprise device makers and the price reflects it
  • ISO 14971:2019 hazard-trace UI is lighter than Greenlight Guru's purpose-built risk module; risk runs through Quality Events and Change Control
  • Roadmap is set by Veeva not the customer; large enterprise device makers occasionally report feature-prioritisation frustration
Best for

Top-tier medical device enterprises already standardised on the Veeva Vault platform who want QualityOne, RIM, QualityDocs, Training, and Clinical under one vendor.

Worst for

Mid-market and venture-stage device makers without an existing Vault contract; you are paying for a platform you do not otherwise need.

Key features

  • 21 CFR Part 11 validated at platform level (cloud)
  • Document Control with revision management and approval workflow
  • Training management aligned to job role and SOP version
  • Quality Events, CAPA, and Change Control closed-loop workflow
  • Audit management with notified-body and FDA inspection mode
  • Supplier quality + supplier-audit tracking
  • Complaint handling tied to UDI and lot
  • Native integration with Vault RIM (510(k), De Novo, EU MDR)
  • Three releases per year (no on-prem upgrade burden)

Integrations

80+ native. Notable: Vault RIM, Vault QualityDocs, Vault Training, Vault Clinical (CTMS / eTMF for ISO 14155), SAP, Oracle, Microsoft Entra ID, Salesforce.

Target size

500 to 1,00,000 employees · US · Canada · EU · UK · Switzerland · Ireland · APAC · LATAM

#5

ETQ Reliance

ETQ (a Hexagon company) · Founded 1992 · Burlington, MA, USA

Configurable medical-device QMS with deep supplier management for mid-market manufacturers and IVD makers.

Opaque pricingG2 4.3 · Capterra 4.4 · 220+ reviews

Summary

ETQ was founded in 1992 in Massachusetts and has built a configurable quality management platform spanning medical devices, IVD diagnostics, life sciences, automotive, food and beverage, and electronics. Hexagon AB acquired ETQ in August 2022 for 1.2 billion dollars and folded it into Hexagon's Manufacturing Intelligence division. ETQ Reliance NXG is the cloud-native architecture with a no-code configuration layer; 40+ pre-built applications cover Document Control, Training, Deviations, CAPA, Change Control, Audit, Supplier Rating, and Complaint Handling. Strength is configurability and a strong supplier-rating module; weakness is implementation complexity and a deeper learning curve than newer SaaS entrants.

Strengths
  • 30+ year operating history with quality management across medical-device, IVD, and broader manufacturing verticals
  • Hexagon AB ownership since August 2022 brings public-parent stability (STO: HEXA-B) and Manufacturing Intelligence integration
  • Reliance NXG cloud-native architecture with a no-code configuration layer; 40+ pre-built applications
  • Deep supplier rating and supplier-audit modules; strong fit for device supply chains with hundreds of component and contract-manufacturer vendors under 21 CFR 820.50
  • 21 CFR Part 11 validated cloud platform that transfers as audit-trail depth for QMSR and ISO 13485
  • G2 4.3 out of 5 across 200+ reviews; recognised in the LNS Research EQMS leaderboard
Weaknesses
  • Hexagon ownership cuts both ways; some customers report slower roadmap velocity for device-specific features post-2022 acquisition
  • Pricing is opaque; SmartSuite and ComplianceRated triangulate 50K-150K dollars+ entry for mid-size device manufacturers
  • Configuration layer is deep but requires admin training; greenfield deployments routinely run 4-9 months with SI partner support
  • G2 reviewers report the platform feels engineered for cross-industry rather than device-first; some device-specific workflows require configuration (e.g., dedicated UDI tracking)
  • Smaller medical-device install base than MasterControl, Veeva Vault QualityOne, or Sparta TrackWise Digital
  • ISO 14971:2019 risk-matrix UI is lighter than Greenlight Guru's purpose-built risk module
Best for

Mid-market medical-device and IVD manufacturers (500-5,000 employees) that want a configurable QMS with deep supplier management and the option to expand to multiple plants under one tenant.

Worst for

Top-20 device enterprises with global multi-region deployment needs; Veeva Vault QualityOne and MasterControl fit that brief better.

Key features

  • 21 CFR Part 11 validated cloud platform (Reliance NXG)
  • Document Control with revision management and approval workflow
  • Deviations + CAPA + Change Control closed-loop workflow
  • Training management aligned to job role and SOP version
  • Audit management (internal + external + notified-body)
  • Supplier rating + supplier-audit modules
  • Complaint handling tied to UDI and lot
  • No-code configuration via Reliance NXG
  • 40+ pre-built quality applications

Integrations

50+ native. Notable: SAP, Oracle, Microsoft Entra ID, Okta, Salesforce, Hexagon Manufacturing Intelligence, Custom REST API.

Target size

200 to 50,000 employees · US · Canada · EU · UK · APAC

#6

Sparta TrackWise Digital

Sparta Systems (a Honeywell company) · Founded 1994 · Hamilton, NJ, USA

Original device + diagnostic QMS heritage now backed by Honeywell with AI-enriched quality outcomes.

Opaque pricingG2 4.1 · Capterra 4.3 · 150+ reviews

Summary

Sparta Systems was founded in 1994 in New Jersey and has been one of the largest installed device and diagnostic quality management bases for most of its 30-year history. Honeywell acquired Sparta in January 2021 for 1.3 billion dollars and folded it into Honeywell Connected Enterprise. TrackWise Digital is the cloud-native successor to the legacy TrackWise on-prem product; the platform spans Deviations, CAPA, Change Control, Complaints, Audits, and Supplier Management. Sparta launched AI-Enriched Quality Outcomes in 2024 and 2025 with Honeywell Forge underpinning the data layer. Strength is depth of device quality heritage and Honeywell stewardship; weakness is the legacy-to-cloud migration story and pricing that mirrors MasterControl.

Strengths
  • 30-year operating history with device and diagnostic quality systems; TrackWise has been a category staple since 1994
  • Honeywell ownership since January 2021 provides public-company stability and Connected Enterprise investment
  • AI-Enriched Quality Outcomes shipped 2024-2025 with Honeywell Forge data layer underpinning anomaly detection across deviations and CAPA
  • Strong depth in device + diagnostic reference base including major Class II and Class III manufacturers
  • TrackWise Digital cloud-native architecture replaces the legacy on-prem TrackWise product with multi-tenant SaaS
  • Honeywell Connected Plant and MES integration for paperless device shop floors with eDHR adjacency
Weaknesses
  • Legacy-to-cloud migration story is still in flight; long-tenured customers on legacy TrackWise on-prem report 12-18 month re-platforming effort
  • Pricing is opaque; SmartSuite and Gartner Peer Insights triangulate 80K-200K dollars+ entry for mid-size device manufacturers
  • Implementation is consultant-heavy with named Honeywell or SI partner support; 6-12 month timelines typical
  • G2 review volume is smaller than MasterControl or Veeva Vault QualityOne; reference-call pool is narrower for procurement diligence
  • Honeywell ownership cuts both ways; some customers report slower roadmap velocity post-acquisition for device-specific features
  • ISO 14971:2019 hazard-trace UI is lighter than Greenlight Guru's purpose-built risk module
Best for

Mid-large medical-device and IVD manufacturers with an existing TrackWise on-prem footprint or a Honeywell Connected Enterprise relationship who want cloud-native eQMS with AI-enriched analytics.

Worst for

Greenfield device startups under 200 employees; the platform is over-built and the implementation overhead is unjustified.

Key features

  • 21 CFR Part 11 validated cloud platform
  • Deviations + CAPA + Change Control closed-loop workflow
  • Complaint handling tied to UDI and lot
  • Audit management (internal + external + FDA + notified-body)
  • Supplier management with qualification and supplier-audit
  • AI-Enriched Quality Outcomes (anomaly detection across deviations and CAPA)
  • Honeywell Forge data layer for cross-plant quality analytics
  • MES + ERP integrations for paperless device shop floors with eDHR
  • Multi-site and multi-region tenant configuration

Integrations

60+ native. Notable: SAP, Oracle, Honeywell MES, Microsoft Entra ID, Okta, Salesforce, ServiceNow.

Target size

500 to 1,00,000 employees · US · Canada · EU · UK · Switzerland · Ireland · APAC · LATAM

#7

Qualio

Qualio, Inc. · Founded 2012 · San Francisco, CA, USA

Cloud-native multi-tenant eQMS with 60-90 day time-to-validated-deployment for sub-100-employee device startups.

Partial pricingG2 4.6 · Capterra 4.7 · 400+ reviews

Summary

Qualio was founded in 2012 and is a cloud-native, multi-tenant eQMS engineered for emerging medical-device and biotech buyers. Sapphire Ventures led a 50 million dollar Series B in 2021. The platform spans Document Control, Training, CAPA, Change Control, Supplier Management, and design-history-file integrations; pricing is among the most transparent in this ranking with Essentials around 24,000 dollars per year published. Strength is fast time-to-validated-deployment for early-stage device startups under 100 employees and a strong G2 4.6 out of 5 across 380+ reviews; weakness is a lighter ISO 14971:2019 risk module than Greenlight Guru and a thinner enterprise reference base than MasterControl or Veeva.

Strengths
  • Cloud-native multi-tenant SaaS with 60-90 day time to validated deployment for emerging device and biotech startups
  • Transparent published pricing on Essentials tier (~24K dollars per year) which is rare in this category
  • G2 Leader for SMB QMS at 4.6 out of 5 across 380+ reviews; strong NPS for the under-100-employee cohort
  • Independent ownership (Sapphire Ventures led 50M Series B in 2021) without majority-control PE renewal dynamics
  • Qualio Content Pathway for the FDA QMSR transition (Feb 2 2026) helps customers map existing Part 820 content to the harmonised ISO 13485 references
  • Modern UI feels purpose-built for digital-first device startups; lower training overhead than MasterControl or Sparta
Weaknesses
  • ISO 14971:2019 risk module is lighter than Greenlight Guru's purpose-built hazard-trace UI; risk runs through quality-events and CAPA rather than a dedicated risk-matrix engine
  • Sub-100-employee install base; scales to 500-1,000 employees but rarely beyond, so top-20 device enterprises shortlist Veeva or MasterControl instead
  • OpenRegulatory describes Qualio as the new kid on the block fuelled by VC money with pricing for higher tiers as opaque as competitors and rumours of minimum 5-figure-USD-per-year on Plus and above
  • PE-style renewal pressure is not present yet but a Series B is a step on the path; budget for a 3-year cap negotiation
  • Smaller integration marketplace than ETQ or Veeva; ERP integrations focus on NetSuite and Sage Intacct rather than SAP or Oracle E-Business Suite
  • Limited Manufacturing Excellence depth; not a fit for paperless shop-floor eDHR programmes at scale
Best for

Sub-100-employee Class II medical-device and IVD startups that need a fast-deploy validated eQMS with transparent published entry pricing.

Worst for

Top-tier device enterprises and global IVD makers with 5,000+ employees; the platform is engineered for emerging buyers and the value story compresses at scale.

Key features

  • 21 CFR Part 11 validated cloud platform
  • Document Control with revision management and approval workflow
  • Training management aligned to job role and document revision
  • CAPA + nonconforming product + change control closed-loop workflow
  • Supplier management with qualification
  • Audit management (internal + external)
  • ISO 13485:2016 + FDA QMSR aligned content pathway
  • Modern UI with low training overhead
  • 60-90 day time to validated deployment

Integrations

20+ native. Notable: Microsoft Entra ID, Okta, NetSuite, Sage Intacct, Slack, Jira, DocuSign.

Target size

5 to 1,000 employees · US · Canada · EU · UK · APAC

#8

Pilgrim SmartSolve

Pilgrim Quality Solutions (an IQVIA company) · Founded 1993 · Tampa, FL, USA

IQVIA-owned heritage eQMS with deep CAPA + complaint + supplier risk for large device + diagnostic manufacturers.

Opaque pricingG2 4.1 · Capterra 4.3 · 130+ reviews

Summary

Pilgrim Quality Solutions was founded in 1993 in Tampa, Florida and has been a fixture in regulated life-sciences quality for 30+ years. IQVIA (NYSE: IQV) acquired Pilgrim in 2015 and folded it into its Q-Suite offering for regulated life-sciences customers. SmartSolve is the eQMS line spanning Document Control, Training, CAPA, Complaints, Change Control, Audits, and Supplier Management; iComplyGRC is the adjacent compliance and supplier-risk product. The 800+ customer base skews toward regulated device and diagnostic manufacturers. Strength is heritage depth and IQVIA-backed clinical and regulatory adjacencies; weakness is a UI that shows its 30-year heritage and a thinner G2 review volume than MasterControl or Sparta.

Strengths
  • 30-year operating history with regulated device and diagnostic quality systems
  • IQVIA ownership since 2015 brings public-company stability and clinical-research / RIM adjacencies
  • 800+ regulated life-sciences customers including major device and diagnostic manufacturers
  • Strong CAPA, complaint handling, and supplier-management modules built for FDA-inspected device workflows
  • 21 CFR Part 11 validated cloud platform with documented audit-trail depth
  • iComplyGRC adjacency for compliance and supplier risk under one IQVIA vendor relationship
Weaknesses
  • G2 review volume is smaller than MasterControl, Greenlight Guru, Veeva, or Qualio; reference-call pool is narrower for procurement diligence
  • Pricing is opaque; SmartSuite triangulates 70K-180K dollars+ entry for mid-size device manufacturers
  • UI shows its 30-year heritage; newer entrants like Greenlight Guru and Qualio feel more modern out of the box
  • Cloud migration story still in flight for long-tenured on-prem customers; expect 12-18 month re-platforming
  • Implementation is consultant-heavy with named IQVIA or SI partner support; 6-12 month timelines typical
  • ISO 14971:2019 hazard-trace UI is lighter than Greenlight Guru's purpose-built risk module
Best for

Large device + diagnostic manufacturers with existing IQVIA clinical-research or RIM contracts who want a heritage eQMS with deep CAPA + complaint + supplier modules under one IQVIA vendor relationship.

Worst for

Venture-stage device startups under 100 employees; the platform is over-built and the price reflects it.

Key features

  • 21 CFR Part 11 validated cloud platform
  • Document Control with revision management and approval workflow
  • Training management aligned to job role and SOP version
  • Deviations + CAPA + Change Control closed-loop workflow
  • Audit management (internal + external + FDA + notified-body)
  • Complaint handling tied to UDI and lot
  • Supplier management with qualification and supplier-audit
  • iComplyGRC adjacency for compliance and supplier risk
  • IQVIA RIM and clinical-research integration for end-to-end device lifecycle

Integrations

40+ native. Notable: SAP, Oracle, IQVIA RIM, Microsoft Entra ID, Okta, Salesforce, DocuSign.

Target size

200 to 50,000 employees · US · Canada · EU · UK · APAC · LATAM

#9

Optro (formerly AuditBoard)

Optro, Inc. · Founded 2014 · Cerritos, CA, USA

Public-device SOX + internal audit suite with CrossComply multi-framework alongside the eQMS.

Opaque pricingG2 4.6 · Capterra 4.7 · 1820+ reviews

Summary

Optro is the new name for AuditBoard, announced March 9 2026 at the IIA Great Audit Minds conference. The company was founded in 2014 by Daniel Kim and Jay Lee as SOXHUB, rebranded to AuditBoard in 2017, and was acquired by Hg Capital in May 2024 for over 3 billion dollars. The platform leads the category on internal audit and SOX 404 controls testing depth, with CrossComply tying HIPAA, HITRUST, NIST, and ISO 27001 to the SOX evidence layer. For public medical-device companies, Optro is the natural pick when internal audit owns the GRC programme alongside a separate device eQMS. G2 carries 1,585 verified reviews at 4.6 out of 5 as of May 2026.

Strengths
  • 1,585 G2 reviews at 4.6 out of 5 (May 2026); the highest review volume in this ranking
  • Deepest SOX controls testing and ICFR workflow of any platform here, born from the original SOXHUB product
  • Strong internal-audit workflow with planning, fieldwork, issue tracking, and committee-ready reports for public-device audit committees
  • CrossComply ties HIPAA, HITRUST, NIST 800-53, NIST CSF, and ISO 27001 to the SOX evidence layer for public-device compliance teams
  • Fortune 500 reference customers including public medical-device companies and a deep partner ecosystem (Big Four advisory firms)
  • AI features (Optro AI, Midship acquisition) driving automated control-evidence linking and narrative drafting
Weaknesses
  • Not a purpose-built device eQMS; Design Controls, CAPA, and change control are absent at the workflow depth that Greenlight Guru, MasterControl, Veeva Vault QualityOne, or Sparta ship
  • Hg Capital ownership since May 2024 raises typical PE-owned price-uplift risk; expect 10-15% price increases at renewal
  • Brand-rebrand churn (March 2026) means a year of customer-comms work that distracts from product velocity
  • Pricing remains opaque; SmartSuite and ComplianceRated triangulate 30-80K dollars+ entry, scaling to mid-six-figures for enterprise
  • Implementation is consultant-heavy; expect 8-16 week deployment with named SI partner support
  • Less natural fit for private medical-device manufacturers; the SOX 404 depth is wasted if you do not file with the SEC
Best for

Public medical-device companies and Fortune 1000 internal-audit teams running SOX 404 + ICFR who want one platform across internal audit, SOX, third-party, and ESG alongside their separate device eQMS.

Worst for

Private device startups and contract manufacturers under 500 employees; under-priced for a SOX 404 brief that does not apply.

Key features

  • SOX 404 controls testing and ICFR workflow
  • Internal audit planning, fieldwork, and reporting
  • SOC 1 / SOC 2 / ISO 27001 framework support
  • Third-party / supplier risk management
  • ESG and sustainability reporting workflow
  • CrossComply control-mapping across HIPAA, HITRUST, NIST, ISO 27001
  • Optro AI for evidence summarisation and control narratives
  • Connected-risk dashboards for board reporting

Integrations

60+ native. Notable: Workday, NetSuite, SAP, Microsoft Entra ID, Okta, Jira, ServiceNow, Salesforce.

Target size

500 to 1,00,000 employees · US · Canada · UK · EU · AU · APAC

#10

Riskonnect

Riskonnect, Inc. · Founded 2007 · Atlanta, GA, USA

Salesforce-native integrated risk platform with deep product liability and recall management for device manufacturers.

Opaque pricingG2 4.2 · Capterra 4.4 · 200+ reviews

Summary

Riskonnect runs on Salesforce and bundles enterprise risk, claims administration, RMIS, vendor risk, recall management, and business continuity into one data model. The company serves 2,700+ enterprise customers across industries; the medical-device vertical fields product liability, clinical-trial insurance, and recall management modules alongside the broader RMIS. The Ventiv Technology acquisition (closed 2021) added claims administration depth that is hard for non-Salesforce vendors to match. Strength is integrated claims, RMIS, and recall management at enterprise scale; weakness is initial complexity and Salesforce platform-tax for non-Salesforce device shops.

Strengths
  • Deepest claims administration and RMIS in this ranking (Ventiv Technology acquisition closed 2021)
  • Salesforce-native architecture means inherited Salesforce SSO, mobile, reporting, and AppExchange ecosystem
  • Product liability and clinical-trial insurance modules tailored for medical-device and IVD sponsors under ISO 14155
  • Recall management workflow ties product safety events to claims and supplier records in one data layer; critical for Class II and Class III field-action management
  • 200+ integrations via Salesforce AppExchange (Workday, ServiceNow, SAP, Tableau)
  • 2,700+ enterprise customers across six continents
Weaknesses
  • SmartSuite triangulation reports pricing starting at 283K dollars per year; the highest entry point in this ranking
  • Not a purpose-built device eQMS; Design Controls, CAPA, and change control are absent at the workflow depth that Greenlight Guru, MasterControl, or Veeva ship
  • G2 reviewers consistently flag initial complexity and overwhelming UI before familiarity sets in (3-6 month learning curve)
  • Salesforce dependency cuts both ways: non-Salesforce device shops absorb platform-tax they did not budget for
  • Triple-PE ownership (TA, Thoma Bravo, Arrowroot) elevates renewal-pricing pressure; 8-12% annual uplifts reported
  • Implementation timelines for the full claims + RMIS + risk suite typically run 6-9 months with named SI partner
Best for

Medical-device and IVD enterprises with significant product liability exposure or self-insured clinical-trial portfolios that need claims + RMIS + recall management in one Salesforce-native tenant alongside their device eQMS.

Worst for

Sub-200-employee device startups whose primary need is closed-loop Design Controls and DHF workflow; cost-prohibitive and not the right tool for the job.

Key features

  • Salesforce-native data model
  • Product liability and clinical-trial insurance modules
  • Claims administration (Ventiv-derived)
  • Risk Management Information System (RMIS)
  • Enterprise risk management with KRIs
  • Recall management workflow for Class II and Class III field actions
  • Vendor / supplier risk management
  • Internal audit workflow
  • Business continuity and operational resilience
  • Connected risk dashboards for board reporting

Integrations

200+ native. Notable: Salesforce AppExchange ecosystem, SAP, Oracle, ServiceNow, Workday, Tableau, Microsoft Entra ID.

Target size

1,000 to 1,00,000 employees · US · Canada · UK · EU · AU · APAC · LATAM

Step by step

Buying guide

Walk these steps in order. The shortlist falls out of step 1, the negotiation moves come together in step 6, and step 8 closes the deal.

  1. 1

    Name the primary job in one sentence

    Before you shortlist, write down the one job you absolutely must solve. Examples: replace a paper Design Controls binder with electronic DHF compilation; pass an FDA QMSR inspection in 9 months under the new February 2 2026 inspection programme; consolidate device risk records from three contract manufacturers into one tenant; tie product complaints to claims and recall workflow. The shortlist falls out of the one-sentence answer.

  2. 2

    Match the shortlist to your company size and budget

    Filter the ten platforms by employee count and budget band. Under 50 employees with a 50K dollar budget rules out everything except RiskWatch Standard or Professional, Qualio Essentials, and a stripped Greenlight Guru tier. Over 5,000 employees with a 500K+ dollar budget filters back in Veeva Vault QualityOne, MasterControl, Sparta TrackWise Digital, and Riskonnect. Contract manufacturers typically end up at MasterControl or ETQ; venture-stage device startups at Greenlight Guru or Qualio.

  3. 3

    Verify FDA inspection track record and notified-body submissions

    For each shortlisted vendor, ask for three customer references that have hosted an FDA Quality System inspection or an EU MDR notified-body audit on the platform. Read the FDA Warning Letter database and check whether device QSR / QMSR failures involved the platform. MasterControl's FDA-internal usage is a stronger signal than any vendor's marketing copy.

  4. 4

    Confirm DHF data residency and validation transfer

    Your DHF and DMR are regulated. Ask each vendor: where do DHF records live, is it single-tenant or multi-tenant, who has access, what happens to them if you leave, and what is the retention plan past life of device? RiskWatch supports single-tenant deployment with customer-owned data residency. Veeva Vault QualityOne and MasterControl are multi-tenant cloud with documented Part 11 validation. Confirm the validation-transfer documentation that comes with the contract.

  5. 5

    Map the platform to ISO 14971, ISO 13485, QMSR, and EU MDR

    For every shortlist finalist, ask which controls are pre-mapped to ISO 14971:2019, ISO 13485:2016, FDA QMSR / 21 CFR Part 820 (effective February 2 2026), EU MDR 2017/745, IVDR 2017/746, IEC 62366-1, IEC 62304, and the October 2023 FDA cybersecurity guidance. RiskWatch and Greenlight Guru ship these pre-mapped. MasterControl, Veeva, Sparta, ETQ, Qualio, and Pilgrim ship the workflows but expect to map the framework yourself. Optro and Riskonnect require you to bring the framework.

  6. 6

    Ask each vendor for the renewal-escalator cap in writing

    Renewal-pricing pressure is the silent budget killer in this category. MasterControl (TA Associates + Sumeru), Sparta (Honeywell), ETQ (Hexagon), Greenlight Guru (JMI Equity), Pilgrim (IQVIA), Optro (Hg Capital), and Riskonnect (TA + Thoma Bravo + Arrowroot) are all PE- or large-corporate-owned with multi-year roll-ups, which historically signals 8-15% annual uplift pressure. Veeva is public NYSE: VEEV with more stable pricing. Ask for the renewal-escalator cap in the master subscription agreement and walk if the vendor refuses.

  7. 7

    Insist on a working pilot with anonymised DHF data structures

    Demos are choreographed. Working pilots are not. Ask each finalist for a 30-day pilot using anonymised DHF and DMR data structures: one Design Controls trace, one ISO 14971 hazard analysis, one CAPA, one supplier qualification, one complaint linked to UDI. The platform that handles your data without three weeks of professional services is the one that will scale post-deal.

  8. 8

    Triangulate pricing when the vendor will not publish

    Seven of the ten platforms here gate pricing behind a demo. For each opaque vendor, pull at least two independent third-party price triangulations (SmartSuite, ComplianceRated, OpenRegulatory, LNS Research, Gartner Peer Insights) and use them as your anchor in negotiation. Walk in with a 3-year TCO number including implementation, validation services, integration, training, and the renewal-escalator cap.

Frequently asked

Buyer questions, answered

The eight questions our pre-sales team hears the most often when buyers compare this category.

What is medical device risk management software?
Medical device risk management software is the category of platforms that help device manufacturers, in vitro diagnostic (IVD) makers, and contract manufacturers identify, score, and treat product, clinical, supply chain, and compliance risk under one tenant. Typical jobs include ISO 14971:2019 risk analysis, ISO 13485:2016 quality management, FDA QMSR / 21 CFR Part 820 (effective February 2 2026), EU MDR 2017/745 and IVDR 2017/746 technical documentation, IEC 62366-1 usability engineering, IEC 62304 software lifecycle for SaMD, and FDA premarket cybersecurity. The ten platforms in this ranking each cover at least two of those jobs.
How is an electronic quality management system (eQMS) different from a risk management platform for medical devices?
An eQMS (Greenlight Guru, MasterControl, Veeva Vault QualityOne, ETQ Reliance, Sparta TrackWise Digital, Qualio, Pilgrim SmartSolve) is the closed-loop workflow tool for Design Controls, Document Control, Training, CAPA, Change Control, complaints, audits, and supplier qualification under ISO 13485 and 21 CFR Part 820 / QMSR. A risk management platform (RiskWatch, Riskonnect, Optro) sits above or alongside the eQMS and runs the ISO 14971 risk register, enterprise risk roll-up, claims, and recall management. Most device makers run one eQMS plus one risk-or-claims platform; the few largest enterprises run both plus a separate SOX or audit platform.
How much should a medical device manufacturer budget for risk management software in 2026?
Pricing ranges from 1,188 dollars per year (RiskWatch Standard at 99 dollars per month) and 24,000 dollars per year (Qualio Essentials published) to 800K+ dollars per year (Veeva Vault QualityOne global device, Riskonnect full-suite at 283K+ entry). For a mid-size manufacturer (500-2,500 employees) running an eQMS plus supplier risk plus ISO 14971 risk, expect 80K-250K dollars per year on licence plus 20-30% implementation. For top-20 device enterprises running QualityOne plus a separate RMIS plus a separate SOX platform, expect 750K-2M+ dollars per year across vendors. Always model 3-year TCO, ask for the renewal-escalator cap in writing, and confirm whether DHF data residency is single-tenant or multi-tenant.
What does the FDA QMSR mean and which platforms support it?
The Quality Management System Regulation (QMSR) is the FDA Final Rule published February 2 2024 amending 21 CFR Part 820 to incorporate ISO 13485:2016 by reference. The Final Rule became effective February 2 2026 and FDA began using the updated Inspection of Medical Device Manufacturers Compliance Program 7382.850 on that date. ISO 13485 alone is not sufficient because the QMSR adds FDA-specific requirements; manufacturers should run a comparative analysis of pre-QMSR documents against QMSR requirements. MasterControl, Greenlight Guru, Veeva Vault QualityOne, ETQ Reliance, Sparta TrackWise Digital, Qualio, and Pilgrim SmartSolve all ship pre-validated cloud platforms with documented QMSR content paths. RiskWatch ships QMSR risk-assessment and gap-analysis workflow with the controls pre-mapped.
Which platforms best support ISO 14971:2019 risk management?
Greenlight Guru ships the deepest ISO 14971:2019 risk module in this ranking, with a dedicated hazard-trace UI covering hazard identification, harm, severity, probability, risk evaluation, risk control, residual risk, and benefit-risk determination across the lifecycle, plus harmonised IMDRF terms beyond FMEA. RiskWatch ships an ISO 14971 control library aligned to the 2019 revision and the 2021 Amendment with assessment workflow that ties hazards to evidence and CAPA. MasterControl, Veeva Vault QualityOne, ETQ Reliance, Sparta TrackWise Digital, Qualio, and Pilgrim SmartSolve embed ISO 14971-style risk assessment into their deviation, CAPA, and change-control workflows; favor platforms with explicit risk-rationale capture rather than dropdowns.
How do these platforms support EU MDR 2017/745 and IVDR 2017/746?
EU MDR (date of application May 26 2021) and IVDR (date of application May 26 2022) require technical documentation under Annex II and Annex III, clinical evaluation, post-market surveillance, and PSUR plus PMCF reporting; transitional timelines were extended under Regulation 2023/607 for MDR legacy devices (May 2024 / Dec 2027 / Dec 2028 by class) and amended for IVDR in July 2024. Greenlight Guru, MasterControl, Veeva Vault QualityOne, and ETQ Reliance ship pre-built MDR Annex II structures. RiskWatch ships MDR and IVDR risk-assessment and gap-analysis workflow with controls pre-mapped. Veeva Vault RIM (sister to QualityOne) is the strongest 510(k), De Novo, and EU MDR submission engine in this ranking.
What about IEC 62366 usability engineering and IEC 62304 software lifecycle?
IEC 62366-1:2015 (with Amendment 1:2020) specifies the usability engineering process and is the standard most teams cite to support EU MDR Annex I General Safety and Performance Requirements for usability. IEC 62304:2006 (with Amendment 1:2015) specifies medical device software lifecycle processes for SaMD and is the standard FDA reviewers cite alongside the October 2023 final cybersecurity guidance. RiskWatch ships IEC 62366 and IEC 62304 control libraries; Greenlight Guru ships purpose-built usability engineering and software-lifecycle workflows. Specialist requirements and ALM tools (Jama Connect, Polarion ALM, Codebeamer) sit underneath for software design history and verification.
What does the October 2023 FDA cybersecurity guidance require for device manufacturers?
FDA finalised Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions on September 27 2023 (published in October 2023). The final guidance requires a Secure Product Development Framework (SPDF), threat modelling, software bill of materials (SBOM) for premarket submissions, vulnerability disclosure plans, and post-market patch management for cyber devices. RiskWatch ships FDA cybersecurity premarket content as a pre-mapped library; Greenlight Guru ties cybersecurity controls to Design Controls and Risk Management; MasterControl, Veeva Vault QualityOne, and Sparta address it through Document Control and Change Control workflows.
Definitions

Glossary

Definitions for the acronyms and jargon used on this page. Useful for sharing with non-specialist stakeholders on the buying committee.

ISO 14971:2019
International standard for the application of risk management to medical devices. The 2019 revision (with Amendment 11:2021) is the current edition. Covers hazard identification, risk analysis, risk evaluation, risk control, residual risk evaluation, and benefit-risk determination across the product lifecycle. Cited by FDA, EU notified bodies, PMDA, and Health Canada.
ISO 13485:2016
International standard for quality management systems for medical devices. Now incorporated by reference into the FDA Quality Management System Regulation (QMSR) under 21 CFR Part 820, effective February 2 2026. Compliance with ISO 13485 alone is not sufficient to fulfil the QMSR; FDA-specific additions apply.
FDA QMSR
Quality Management System Regulation. The FDA Final Rule published February 2 2024 amending 21 CFR Part 820 to incorporate ISO 13485:2016 by reference. Effective February 2 2026. FDA began using the updated Inspection of Medical Device Manufacturers Compliance Program 7382.850 on that date.
EU MDR / IVDR
Regulation (EU) 2017/745 Medical Device Regulation (MDR; date of application May 26 2021) and Regulation (EU) 2017/746 In Vitro Diagnostic Regulation (IVDR; date of application May 26 2022). Transitional timelines were extended under Regulation 2023/607 for MDR legacy devices (May 2024 / Dec 2027 / Dec 2028 by risk class) and amended for IVDR in July 2024.
IEC 62366-1
International standard for the application of usability engineering to medical devices (2015 edition with Amendment 1:2020). Specifies a process for analysing, specifying, developing, and evaluating the usability of a medical device as it relates to safety. Cited as the standard underpinning EU MDR Annex I usability General Safety and Performance Requirements.
IEC 62304
International standard for medical device software lifecycle processes (2006 edition with Amendment 1:2015). Governs software development, maintenance, configuration management, and problem resolution for software as a medical device (SaMD) and software in a medical device. Cited by FDA reviewers alongside the October 2023 cybersecurity guidance.
Design History File (DHF) / DMR
Design History File (DHF) is the compilation of records describing the design history of a finished device, required under 21 CFR 820.30(j). Device Master Record (DMR) is the compilation of records containing the procedures and specifications for a finished device, required under 21 CFR 820.181. Both must be retained for the life of the device plus a defined period.
Final word

Which medical device platform should you pick?

If you read this page top to bottom and one platform stood out, that is your answer. The methodology is on this page so you can disagree with the rank and arrive at a different first pick honestly. We ranked RiskWatch first because the methodology weights favour pre-mapped framework breadth, single-tenant DHF data residency, and pricing-transparency willingness; if your one job is a closed-loop Design Controls and DHF workflow with FDA inspection history, Greenlight Guru, MasterControl, or Veeva Vault QualityOne will rank higher on your matrix.

The one thing every medical device buyer should do, regardless of which vendor wins your bake-off, is to insist on a 30-day working pilot using anonymised DHF and DMR data structures, a renewal-escalator cap in writing, and a documented exit clause covering export format, retention period, and validation-transfer documentation. The buyers we see lose three-year deals always lose them on those three terms, not on workflow feature coverage.

If you would like the RiskWatch medical device demo, sign up at riskwatch.com/request-a-demo. If you would like a no-strings second-opinion on one of the other nine, email sales@riskwatch.com with the vendor name in the subject line and we will share what we know.

Request a Demo